Replay available

4BASEBIO PLC (4BB) — Investor Presentation

Investor Presentation hosted by 4BASEBIO PLC (LSE: 4BB) on Investor Meet Company, held 2026-06-29.

Mon, June 29, 2026 at 12:00 PMendedReplay
4BASEBIO PLC (4BB) — Investor Presentation

Hosted by

Featured presenters

Christine Wolosin

Chief Commercial Officer at 4BASEBIO PLC

Amy Walker

Chief Executive Officer at 4BASEBIO PLC

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for 4basebio Plc.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0430d-c9ea-7983-9698-412ea411bca0 Created: 2026-08-27T11:49:36.455Z Duration: 2603.098 Channels: 1 00:00:00.799 -- 00:00:03.439 Good afternoon, and welcome to the 4BASEBIO PLC 00:00:03.439 -- 00:00:04.640 investor presentation. 00:00:04.640 -- 00:00:06.960 Throughout this recorded presentation, investors will be in 00:00:06.960 -- 00:00:09.200 listen only mode. Questions are encouraged and could 00:00:09.200 -- 00:00:10.800 be submitted at any time via the Q 00:00:10.800 -- 00:00:12.240 and A tab situated on the right hand 00:00:12.240 -- 00:00:14.000 corner of your screen. Simply type in your 00:00:14.000 -- 00:00:16.135 questions and press send. The company may not 00:00:16.135 -- 00:00:17.575 be in a position to answer every question 00:00:17.575 -- 00:00:19.735 it receives during the meeting itself. However, the 00:00:19.735 -- 00:00:21.815 company can review all questions submitted today and 00:00:21.815 -- 00:00:24.134 publish responses where it's appropriate to do so. 00:00:24.135 -- 00:00:25.895 Before we begin, I'd like to submit the 00:00:25.895 -- 00:00:27.974 following poll. I'd now like to hand you 00:00:27.974 -- 00:00:29.575 over to Amy Walker, CEO. 00:00:31.260 -- 00:00:32.380 Thank you very much. 00:00:34.220 -- 00:00:35.660 So I'd like to start off today with 00:00:35.660 -- 00:00:38.700 4BASEBIO's mission statement, and that's really through our 00:00:38.700 -- 00:00:42.140 enzymatically produced DNA, we enable clinical and commercial 00:00:42.140 -- 00:00:43.260 biomanufacturing 00:00:43.260 -- 00:00:44.780 for advanced therapeutics, 00:00:44.780 -- 00:00:45.660 empowering safer, 00:00:46.055 -- 00:00:46.934 faster, 00:00:47.015 -- 00:00:49.655 more cost effective treatments to improve ...